Skip to content

Sharing successes, challenges and daily happenings in the Department of Medicine

kbennett

Trends of Randomized Clinical Trials Citing Prior Systematic Reviews, 2007-2021

ARTICLE: Trends of Randomized Clinical Trials Citing Prior Systematic Reviews, 2007-2021 AUTHORS: Yuanxi Jia, Bingli Li, Zhirong Yang, Fuxiao Li, Ziyi Zhao, Chang Wei, Xuhao Yang, Qianyi Jin, Di Liu, Xin Wei, Jennifer Yost, Hans Lund, Jinling… Read More »Trends of Randomized Clinical Trials Citing Prior Systematic Reviews, 2007-2021

Transcriptomic profiling reveals distinct subsets of immune checkpoint inhibitor induced myositis

ARTICLE: Transcriptomic profiling reveals distinct subsets of immune checkpoint inhibitor induced myositis AUTHORS: Iago Pinal-Fernandez, Angela Quintana, Jose Cesar Milisenda, Maria Casal-Dominguez, Sandra Muñoz-Braceras, Assia Derfoul, Jiram Torres-Ruiz, Katherine Pak, Stefania Dell'Orso, Faiza Naz, Gustavo… Read More »Transcriptomic profiling reveals distinct subsets of immune checkpoint inhibitor induced myositis

Documentation of results and medication prescribing after combinatorial psychiatric pharmacogenetic testing: A case for discrete results

ARTICLE: Documentation of results and medication prescribing after combinatorial psychiatric pharmacogenetic testing: A case for discrete results AUTHORS: John Loftus, Howard P Levy, James M Stevenson JOURNAL:… Read More »Documentation of results and medication prescribing after combinatorial psychiatric pharmacogenetic testing: A case for discrete results

Changes in Spirometry Interpretative Strategies: Implications for Classifying COPD and Predicting Exacerbations

ARTICLE: Changes in Spirometry Interpretative Strategies: Implications for Classifying COPD and Predicting Exacerbations AUTHORS: J Henry Brems, Aparna Balasubramanian, Sarath Raju, Nirupama Putcha, Ashraf Fawzy, Nadia N Hansel, Robert A Wise, Meredith… Read More »Changes in Spirometry Interpretative Strategies: Implications for Classifying COPD and Predicting Exacerbations

Comparative safety and effectiveness of TNF inhibitors, IL6 inhibitors and methotrexate for the treatment of immune checkpoint inhibitor-associated arthritis

ARTICLE: Comparative safety and effectiveness of TNF inhibitors, IL6 inhibitors and methotrexate for the treatment of immune checkpoint inhibitor-associated arthritis AUTHORS: Anne R Bass, Noha Abdel-Wahab, Pankti… Read More »Comparative safety and effectiveness of TNF inhibitors, IL6 inhibitors and methotrexate for the treatment of immune checkpoint inhibitor-associated arthritis